Back

Acetazolamide for patients with acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy for worsening heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mangesh Kritya

Inamdar Multispecialty Hospital, Pune (India)

4 More presentations in this session

Presentation thumbnail
Left ventricular dysfunction, pulmonary congestion, or both and cardiovascular risk after acute myocardial infarction
Doctor J. Tavares Nunes (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Diuretic therapy strategies in decompensated acute heart failure: a systematic review and network metanalysis
Doctor G. Anastasia (Genoa, IT)
Abstract Slides Video
Presentation thumbnail
Acute hemodynamic effect of oral ketones in patients with acutely decompensated heart failure and low cardiac output syndrome: a prospective randomized study.
Doctor M. Sramko (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Paracetamol and adverse cardiovascular outcomes in patients with heart failure
Doctor Q. Ren (Hong Kong, HK)
Abstract Slides

Access the full session

Session thumbnail
Pharmacotherapy for worsening heart failure
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Acetazolamide as an adjunct to loop diuretics in decongesting patients with acute decompensated heart failure: a systematic review and meta-analysis
thumbnail
Congress Presentation
Combination oral acetazolamide and intravenous furosemide on acute decompensated heart failure
thumbnail
Congress Presentation
Could combined diuretic therapy increase decongestion in patients with acute heart failure?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources